Incentives for R&D: Payment Options and Pricing Challenges

Pedro Barros

Seminar Briefing from Office of Health Economics

Abstract: The issue of rising prescription drug prices is a concern in every country. Dozens of policy initiatives and hundreds of research projects over last the fifty years have attempted to find solutions to pricing that provide an appropriate balance between the cost to health care systems and incentives for R&D. To name but a few, these include reference pricing, managed entry agreements, price-volume agreements, rebates, and risk sharing. The ultimate solution, however, remains elusive.

Keywords: Incentives; for; R&D:; Payment; Options; and; Pricing; Challenges (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2020-08-01
New Economics Papers: this item is included in nep-ino
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/incentives-rd-pay ... fing-pedro-lt-003-1/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:sembri:002289

Access Statistics for this paper

More papers in Seminar Briefing from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).